BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26298169)

  • 1. Resected Lung Cancer Patients Who Would and Would Not Have Met Screening Criteria.
    Farjah F; Wood DE; Zadworny ME; Rusch VW; Rizk NP
    Ann Thorac Surg; 2016 Jan; 101(1):274-9. PubMed ID: 26298169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating efficacy of current lung cancer screening guidelines.
    Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
    J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
    Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
    PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
    Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
    Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stratification and management of patients ineligible for lung cancer screening.
    Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G
    Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
    Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
    Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
    Hüsing A; Kaaks R
    Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
    Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
    Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
    Wu GX; Goldstein L; Kim JY; Raz DJ
    Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
    Pinsky PF; Berg CD
    J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
    Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
    Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pack-Year Cigarette Smoking History for Determination of Lung Cancer Screening Eligibility. Comparison of the Electronic Medical Record versus a Shared Decision-making Conversation.
    Modin HE; Fathi JT; Gilbert CR; Wilshire CL; Wilson AK; Aye RW; Farivar AS; Louie BE; Vallières E; Gorden JA
    Ann Am Thorac Soc; 2017 Aug; 14(8):1320-1325. PubMed ID: 28406708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
    Criss SD; Sheehan DF; Palazzo L; Kong CY
    PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
    Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
    J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-Based lung cancer screening: A systematic review.
    Toumazis I; Bastani M; Han SS; Plevritis SK
    Lung Cancer; 2020 Sep; 147():154-186. PubMed ID: 32721652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Subpopulations at High Risk for Lung Cancer.
    Yang P; Wang Y; Wampfler JA; Xie D; Stoddard SM; She J; Midthun DE
    J Thorac Oncol; 2016 Feb; 11(2):194-202. PubMed ID: 26811226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.